Synaffix B.V., a Lonza company (SIX:LONN) focused on commercializing its clinical-stage bioconjugation platform technology for the ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

(NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced updates to its agreement with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based ...

Find earnings, economic, stock splits and IPO calendars to track upcoming financial events from Yahoo Finance.

ESYA Labs, a global leader in lysosomal biology and biomarker discovery for neurodegenerative diseases, has announced a transformative partnership with Alamar Biosciences, a pioneer in ultra-sensitive ...

Wags Animal Hospital in Brickell Key, Florida is pleased to announce that veterinarian Dr. Liliana Roa Garcia has completed clinical training on advanced techniques in soft-tissue and oncology surgery ...

Wales has extended a scheme to harness the power of genomics to improve cancer care and prevention via an alliance with gene-sequencing giant Illumina ... of cell-free DNA (cfDNA) that leak ...

This interesting study presents valuable information on how human cytomegalovirus (HCMV) infection disrupts the activity of the TEAD1 transcription factor, leading to widespread chromatin alterations.

The growing trend for personalized medicines is driving market growth.New York, USA, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Market ...

After hours: 29 November at 16:21 GMT-5 ...

After hours: November 29 at 4:21 p.m. EST ...